An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer

NCT03243331 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: Gedatolisib
DRUG: PTK7-ADC

Sponsor

Kathy Miller